Antiviral Agents (blood) < Antiviral Agents (chemical synthesis) < Antiviral Agents (chemistry)

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 85.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000012 (2001)	C E Stephens [États-Unis] ; T M Felder ; J W Sowell ; G. Andrei ; J. Balzarini ; R. Snoeck ; E. De Clercq	Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones.
000360 (2003)	Christopher Mcguigan [Royaume-Uni] ; Alison Jukes ; Sally Blewett ; Hubert Barucki ; Jonathan T. Erichsen ; Graciella Andrei ; Robert Snoeck ; Erik De Clercq ; Jan Balzarini	Halophenyl furanopyrimidines as potent and selective anti-VZV agents.
000372 (2003)	Andreas J. Kesel [Allemagne]	A system of protein target sequences for anti-RNA-viral chemotherapy by a vitamin B6-derived zinc-chelating trioxa-adamantane-triol.
000420 (2003)	Ekachai Jenwitheesuk [États-Unis] ; Ram Samudrala	Identifying inhibitors of the SARS coronavirus proteinase.
000798 (2004)	Mayuko Takeda-Shitaka [Japon] ; Hiroyuki Nojima ; Daisuke Takaya ; Kazuhiko Kanou ; Mitsuo Iwadate ; Hideaki Umeyama	Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design.
000956 (2004)	Bo-Jian Zheng [République populaire de Chine] ; Yi Guan ; Qingquan Tang ; Cheng Du ; Frank Y. Xie ; Ming-Liang He ; Kwok-Wah Chan ; Kin-Ling Wong ; Eric Lader ; Martin C. Woodle ; Patrick Y. Lu ; Baojian Li ; Nanshan Zhong	Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus.
000A80 (2004)	Richard Y. Kao [République populaire de Chine] ; Wayne H W. Tsui ; Terri S W. Lee ; Julian A. Tanner ; Rory M. Watt ; Jian-Dong Huang ; Lihong Hu ; Guanhua Chen ; Zhiwei Chen ; Linqi Zhang ; Tian He ; Kwok-Hung Chan ; Herman Tse ; Amanda P C. To ; Louisa W Y. Ng ; Bonnie C W. Wong ; Hoi-Wah Tsoi ; Dan Yang ; David D. Ho ; Kwok-Yung Yuen	Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
000D91 (2005)	Gerold Hoever [Allemagne] ; Lidia Baltina ; Martin Michaelis ; Rimma Kondratenko ; Lia Baltina ; Genrich A. Tolstikov ; Hans W. Doerr ; Jindrich Cinatl	Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.
000E13 (2005)	Yossef Kliger ; Erez Y. Levanon ; Doron Gerber	From genome to antivirals: SARS as a test tube
001021 (2005)	Jiun-Jie Shie [Taïwan] ; Jim-Min Fang ; Chih-Jung Kuo ; Tun-Hsun Kuo ; Po-Huang Liang ; Hung-Jyun Huang ; Wen-Bin Yang ; Chun-Hung Lin ; Jiun-Ling Chen ; Yin-Ta Wu ; Chi-Huey Wong	Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
001111 (2005)	Andreas J. Kesel [Allemagne]	Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS).
001135 (2005)	Haitao Yang [République populaire de Chine] ; Weiqing Xie ; Xiaoyu Xue ; Kailin Yang ; Jing Ma ; Wenxue Liang ; Qi Zhao ; Zhe Zhou ; Duanqing Pei ; John Ziebuhr ; Rolf Hilgenfeld ; Kwok Yung Yuen ; Luet Wong ; Guangxia Gao ; Saijuan Chen ; Zhu Chen ; Dawei Ma ; Mark Bartlam ; Zihe Rao	Design of wide-spectrum inhibitors targeting coronavirus main proteases.
001229 (2005)	Arun K. Ghosh [États-Unis] ; Kai Xi ; Kiira Ratia ; Bernard D. Santarsiero ; Wentao Fu ; Brian H. Harcourt ; Paul A. Rota ; Susan C. Baker ; Michael E. Johnson ; Andrew D. Mesecar	Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
001330 (2006)	Pi-Hui Liang [Taïwan] ; Wei-Chieh Cheng ; Yi-Ling Lee ; Han-Pang Yu ; Ying-Ta Wu ; Yi-Ling Lin ; Chi-Huey Wong	Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.
001361 (2006)	Jong Hyun Cho [États-Unis] ; Dale L. Bernard ; Robert W. Sidwell ; Earl R. Kern ; Chung K. Chu	Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS.
001362 (2006)	Han-Zhong Zhang [États-Unis] ; Hong Zhang ; William Kemnitzer ; Ben Tseng ; Jindrich Cinatl ; Martin Michaelis ; Hans Wilhelm Doerr ; Sui Xiong Cai	Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.
001476 (2006)	Christophe Biot [France] ; Wassim Daher ; Natascha Chavain ; Thierry Fandeur ; Jamal Khalife ; Daniel Dive ; Erik De Clercq	Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities.
001526 (2006)	Rakesh Kumar [Canada] ; Wassila Semaine ; Monika Johar ; D Lorne J. Tyrrell ; Babita Agrawal	Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
001599 (2006)	Syaulan Yang [République populaire de Chine] ; Shu-Jen Chen ; Min-Feng Hsu ; Jen-Dar Wu ; Chien-Te K. Tseng ; Yu-Fan Liu ; Hua-Chien Chen ; Chun-Wei Kuo ; Chi-Shen Wu ; Li-Wen Chang ; Wen-Chang Chen ; Shao-Ying Liao ; Teng-Yuan Chang ; Hsin-Hui Hung ; Hui-Lin Shr ; Cheng-Yuan Liu ; Yu-An Huang ; Ling-Yin Chang ; Jen-Chi Hsu ; Clarence J. Peters ; Andrew H-J Wang ; Ming-Chu Hsu	Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor.
001774 (2006)	Christopher Mcguigan [Royaume-Uni] ; Alshaimaa Hassan-Abdallah ; Sheila Srinivasan ; Yikang Wang ; Adam Siddiqui ; Susan M. Daluge ; Kristjan S. Gudmundsson ; Huiqiang Zhou ; Ed W. Mclean ; Jennifer P. Peckham ; Thimysta C. Burnette ; Harry Marr ; Richard Hazen ; Lynn D. Condreay ; Lance Johnson ; Jan Balzarini	Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
001792 (2006)	Masahiro Ikejiri [Japon] ; Masayuki Saijo ; Shigeru Morikawa ; Shuetsu Fukushi ; Tetsuya Mizutani ; Ichiro Kurane ; Tokumi Maruyama	Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiviral Agents (chemical synthesis)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiviral Agents (chemical synthesis)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (chemical synthesis)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021